Friday, April 24, 2020

[Targeted molecular therapy and immunotherapy for prostate cancer].

[Targeted molecular therapy and immunotherapy for prostate cancer].: For decades, the treatment of advanced prostate cancer was mainly based on the manipulation of the androgen receptor-controlled proliferation pathway. Chemotherapy only played an additional important role with the advent of taxanes.

No comments: